Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

294.92 -3.51 (-1.18%)
Streaming Delayed Price Updated: 10:21 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan
Via The Motley Fool
Martin Capital Exits $5.8 Million Comcast Stake as Broadband Challenges Persist
Via The Motley Fool
Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings
Via The Motley Fool
Amgen To Sell Cholesterol Drug For Approximately 60% Discount
Patients can purchase Repatha at a discount through Amgen’s direct-to-patient program, AmgenNow. 
Via Stocktwits
Topics Government
P/E Ratio Insights for Amgen
 
Via Benzinga
4 Reasons to Buy Amgen Stock Right Now
For those with a sufficiently long investment horizon, the stock looks attractive. 
Via The Motley Fool
Topics Intellectual Property
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets
S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech. 
Via Benzinga
Topics Artificial Intelligence Stocks
FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape
In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca... 
Via MarketMinute
U.S. Jobs Report Stalled Amidst Federal Shutdown: A Critical Information Vacuum for Markets and Policymakers
Washington D.C., October 2, 2025 – As a federal government shutdown extends into its second day, the highly anticipated U.S. Jobs Report, typically released on the first Friday of each month, has been... 
Via MarketMinute
Topics Bonds Economy
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount. 
Via Benzinga
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented... 
Via TokenRing AI
Topics Artificial Intelligence
Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen
Check out the companies making headlines yesterday: 
Via StockStory
Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done
What's one piece of advice Dr. Bruce Beutler gives to anyone interested in excelling in science? Go outside. It worked for him. 
Via Investor's Business Daily
2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
These stocks have been raising their payouts much faster than most dividend payers. 
Via The Motley Fool
Topics Economy
Why Are Amgen (AMGN) Shares Soaring Today
Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed... 
Via StockStory
Topics Economy Government Intellectual Property
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. 
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff
Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday. 
Via Investor's Business Daily
Topics Economy Government World Trade
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
Via MarketMinute
Topics Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
Via MarketMinute
Topics Economy Government World Trade
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks
Rep. Marjorie Taylor Greene's latest trades reveal a six-figure Treasury Bill buy, plus new stakes in tech stocks and a Bitcoin ETF. 
Via Benzinga
Topics ETFs
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
Dividend stocks can be a more predictable stream of income for investors. 
Via The Motley Fool
Topics ETFs Stocks
Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies to reduce drug prices in the U.S. to the levels paid by other developed countries. 
Via Stocktwits
Topics Government
Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025
Instead of choosing just one or two stocks, buy a bunch of quality dividend-payers with a single ETF. 
Via The Motley Fool
Topics ETFs Stocks
Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility
September 26, 2025 – Global financial markets are once again in the throes of uncertainty as the United States unveils a fresh wave of substantial trade tariffs, set to take effect on October 1, 2025.... 
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Amgen Expands US Manufacturing Network Amid New Tariff Policy
Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc (NASDAQ: AMGN) announced a $650 million expansion of its U.S. manufacturing network. 
Via Benzinga
Topics Government World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.